D
Doccla
Supporting healthcare organisations deliver virtual ward services proven to reduce costs while improving outcomes
About Doccla
Doccla is a health-tech startup that operates in the European market, offering remote patient monitoring solutions. The company's primary clients are healthcare providers, including NHS Trusts and hospitals across more than 10 European countries. Doccla's business model revolves around providing a digital platform that enables healthcare providers to monitor patients remotely, thereby increasing clinical capacity and patient compliance.
The platform includes a patient app and a clinician dashboard. The patient app, designed with user-friendliness in mind, allows patients to submit vital measurements and symptom questions. It is accessible even for elderly patients, thanks to its large font and simple interface. The clinician dashboard, accessible via an internet browser, provides healthcare professionals with easy access to patient data. Doccla integrates with a wide range of patient record systems, ensuring that measurements taken at home are written into the patient's contemporaneous record.
Doccla's revenue model is likely based on a subscription or service fee charged to healthcare providers. The value proposition is clear: for every £1 spent on Doccla, the NHS reportedly saves £3+ compared to non-tech enabled virtual wards. This cost-saving aspect, coupled with the platform's ability to unblock beds and unlock clinical capacity, makes Doccla an attractive solution for healthcare providers.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2019
- Headquarters
- London, United Kingdom
- Employees
- 164
- Open positions
- 8
- Dealroom signal
- 77.9/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Remote Monitoring, Tech for Patients, Govtech and Civictech, Physician Support Tools, Horizon Europe, Digital Care, Preventive Care, radar de l'innovation
- Technology
- IoT InternetOfThings
- Business model
- SaaS
- Client focus
- b2b, b2c
- Investment activity
- 1 company, latest Aug 2023
- Capital deployed
- —
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Sep 2024 | $46M | $185M | Bertelsmann Investments · Lakestar · Elaia · General Catalyst | ↗ |
| CONVERTIBLEOther financing | Nov 2023 | $5.8M | — | Bertelsmann Investments | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Doccla is 21K monthly website visits, up 187.7% over the last three months. Doccla's team grew 1.2% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Speedinvest
Giant Ventures
Series A5 investors entered at this stage
General Catalyst
Meridian Health Ventures
Bertelsmann Investments
Lakestar
Elaia
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Doccla on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Doccla’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.